annual CFF:
$72.40M+$65.50M(+949.41%)Summary
- As of today (July 4, 2025), SPRY annual cash flow from financing activities is $72.40 million, with the most recent change of +$65.50 million (+949.41%) on December 31, 2024.
- During the last 3 years, SPRY annual CFF has risen by +$19.24 million (+36.20%).
- SPRY annual CFF is now -62.04% below its all-time high of $190.73 million, reached on December 31, 2022.
Performance
SPRY Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$725.00K-$70.19M(-98.98%)Summary
- As of today (July 4, 2025), SPRY quarterly cash flow from financing activities is $725.00 thousand, with the most recent change of -$70.19 million (-98.98%) on March 31, 2025.
- Over the past year, SPRY quarterly CFF has increased by +$467.00 thousand (+181.01%).
- SPRY quarterly CFF is now -99.63% below its all-time high of $193.82 million, reached on December 31, 2022.
Performance
SPRY quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$72.87M+$467.00K(+0.65%)Summary
- As of today (July 4, 2025), SPRY TTM cash flow from financing activities is $72.87 million, with the most recent change of +$467.00 thousand (+0.65%) on March 31, 2025.
- Over the past year, SPRY TTM CFF has increased by +$67.03 million (+1148.13%).
- SPRY TTM CFF is now -63.37% below its all-time high of $198.91 million, reached on September 30, 2023.
Performance
SPRY TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
SPRY Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +949.4% | +181.0% | +1148.1% |
| 3 y3 years | +36.2% | +179.8% | +8124.9% |
| 5 y5 years | +1319.9% | - | - |
SPRY Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -62.0% | +949.4% | -99.6% | +146.6% | -63.4% | +2460.4% |
| 5 y | 5-year | -62.0% | +1319.9% | -99.6% | +146.6% | -63.4% | +2460.4% |
| alltime | all time | -62.0% | +1319.9% | -99.6% | +146.6% | -63.4% | +2460.4% |
SPRY Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $725.00K(-99.0%) | $72.87M(+0.6%) |
| Dec 2024 | $72.40M(+949.4%) | $70.92M(>+9900.0%) | $72.40M(+2101.9%) |
| Sep 2024 | - | $680.00K(+24.8%) | $3.29M(-6.8%) |
| Jun 2024 | - | $545.00K(+111.2%) | $3.53M(-39.6%) |
| Mar 2024 | - | $258.00K(-85.7%) | $5.84M(-15.4%) |
| Dec 2023 | $6.90M | $1.80M(+96.0%) | $6.90M(-96.5%) |
| Sep 2023 | - | $921.00K(-67.7%) | $198.91M(+1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $2.85M(+116.4%) | $196.44M(+1.8%) |
| Mar 2023 | - | $1.32M(-99.3%) | $192.96M(+1.2%) |
| Dec 2022 | $190.73M(+258.8%) | $193.82M(<-9900.0%) | $190.73M(-6278.6%) |
| Sep 2022 | - | -$1.56M(+149.8%) | -$3.09M(+101.6%) |
| Jun 2022 | - | -$623.00K(-31.4%) | -$1.53M(+68.6%) |
| Mar 2022 | - | -$908.00K | -$908.00K |
| Dec 2021 | $53.16M(+942.5%) | - | - |
| Dec 2020 | $5.10M | - | - |
FAQ
- What is ARS Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals annual CFF year-on-year change?
- What is ARS Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals quarterly CFF year-on-year change?
- What is ARS Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals TTM CFF year-on-year change?
What is ARS Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of SPRY is $72.40M
What is the all time high annual CFF for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high annual cash flow from financing activities is $190.73M
What is ARS Pharmaceuticals annual CFF year-on-year change?
Over the past year, SPRY annual cash flow from financing activities has changed by +$65.50M (+949.41%)
What is ARS Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of SPRY is $725.00K
What is the all time high quarterly CFF for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high quarterly cash flow from financing activities is $193.82M
What is ARS Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, SPRY quarterly cash flow from financing activities has changed by +$467.00K (+181.01%)
What is ARS Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of SPRY is $72.87M
What is the all time high TTM CFF for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high TTM cash flow from financing activities is $198.91M
What is ARS Pharmaceuticals TTM CFF year-on-year change?
Over the past year, SPRY TTM cash flow from financing activities has changed by +$67.03M (+1148.13%)